EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation

Yasuhiko Sugawara, Sumihito Tamura, Norihiro Kokudo

Hepatitis Research and Treatment · 2010

DOI: 10.1155/2010/475746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatitis Research and Treatment, 2010. Verfasst von Yasuhiko Sugawara und 2 weiteren Autor:innen. Beteiligte Einrichtung: Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology of Japan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A significant proportion of patients with chronic hepatitis C virus (HCV) infection develop liver cirrhosis and complications of end-stage liver disease over two to three decades and require liver transplantation, however, reinfection is common and leads to further adverse events under immunosuppression. Pretransplant antiviral or preemptive therapy is limited to mildly decompensated patients due to poor tolerance. The mainstay of management represents directed antiviral therapy after evidence of recurrence of chronic hepatitis C. Combined pegylated interferon and ribavirin therapy is the current standard treatment with sustained viral response rates of 25% to 45%. The rate is lower than that in the immunocompetent population, partly due to the high prevalence of intolerability. To date, there is no general consensus regarding the antiviral treatment modality, timing, or dosing for HCV in patients with advanced liver disease and after liver transplantation. New anti-HCV drugs to delay disease progression or to enhance viral clearance are necessary.

Autor:innen und Institutionen

  • Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Förderung

  • Ministry of Education, Culture, Sports, Science and Technology of Japan

Zitieren

APA

Sugawara, Y., Tamura, S., & Kokudo, N. (2010). Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation. Hepatitis Research and Treatment. https://doi.org/10.1155/2010/475746

Vancouver

Sugawara Y, Tamura S, Kokudo N. Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation. Hepatitis Research and Treatment. 2010. doi:10.1155/2010/475746

BibTeX
@article{Sugawara2010,
  author = {Sugawara, Yasuhiko and Tamura, Sumihito and Kokudo, Norihiro},
  title = {Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation},
  journal = {Hepatitis Research and Treatment},
  year = {2010},
  doi = {10.1155/2010/475746}
}
Kostenlos starten →